VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

AH Varey; ES Rennel; Y Qiu; HS Bevan; RM Perrin; S Raffy; AR Dixon; C Paraskeva; O Zaccheo; AB Hassan; SJ Harper; DO Bates

VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

AH Varey, ES Rennel, Y Qiu, HS Bevan, RM Perrin, S Raffy, AR Dixon, C Paraskeva, O Zaccheo, AB Hassan, SJ Harper, DO Bates

Research output: Contribution to journal › Article (Academic Journal) › peer-review

Translated title of the contribution	VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
Original language	English
Pages (from-to)	1366-79
Journal	British Journal of Cancer
Volume	98
Publication status	Published - 2008

Handle.net

Persistent link

Cite this

Varey, AH., Rennel, ES., Qiu, Y., Bevan, HS., Perrin, RM., Raffy, S., Dixon, AR., Paraskeva, C., Zaccheo, O., Hassan, AB., Harper, SJ., & Bates, DO. (2008). VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. British Journal of Cancer, 98, 1366-79.

@article{dfc35d1630f1409aaefd9f65dc499b4d,

title = "VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy",

author = "AH Varey and ES Rennel and Y Qiu and HS Bevan and RM Perrin and S Raffy and AR Dixon and C Paraskeva and O Zaccheo and AB Hassan and SJ Harper and DO Bates",

year = "2008",

language = "English",

volume = "98",

pages = "1366--79",

journal = "British Journal of Cancer",

issn = "1532-1827",

publisher = "Springer Nature",

}

Varey, AH, Rennel, ES, Qiu, Y, Bevan, HS, Perrin, RM, Raffy, S, Dixon, AR, Paraskeva, C, Zaccheo, O, Hassan, AB, Harper, SJ & Bates, DO 2008, 'VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy', British Journal of Cancer, vol. 98, pp. 1366-79.

VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. / Varey, AH; Rennel, ES; Qiu, Y et al.
In: British Journal of Cancer, Vol. 98, 2008, p. 1366-79.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

AU - Varey, AH

AU - Rennel, ES

AU - Qiu, Y

AU - Bevan, HS

AU - Perrin, RM

AU - Raffy, S

AU - Dixon, AR

AU - Paraskeva, C

AU - Zaccheo, O

AU - Hassan, AB

AU - Harper, SJ

AU - Bates, DO

PY - 2008

Y1 - 2008

M3 - Article (Academic Journal)

SN - 1532-1827

VL - 98

SP - 1366

EP - 1379

JO - British Journal of Cancer

JF - British Journal of Cancer

ER -